Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoire Pareva is a French specialty chemical company specializing in the development and production of biocidal active substances and disinfectant formulations. The company is recognized as a leading global producer of Polyhexamethylene Biguanide (PHMB), an antimicrobial polymer used extensively in healthcare, water treatment, and industrial hygiene. In 2019, Laboratoire Pareva was acquired by Kersia, a global leader in biosecurity and food safety, to strengthen its portfolio of active ingredients. The company provides high-purity chemical synthesis and regulatory support for biocidal products across international markets. Its operations are centered in Saint-Martin-de-Crau, where it maintains significant manufacturing capacity for active substances.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoire Pareva.